All In MedTech

Device Trial Radar · NCT02537353

Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip

Prospective, Randomized Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip Plus Epinephrine Injection in Nonvariceal Upper Gastrointestinal Bleeding

Last checked: Nov 19, 2026Latest source record: Sep 1, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Sep 2015

Primary completion

Jul 2017

Study completion Aug 2017

Sponsor

Lead sponsor
University of Sao Paulo General HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 1, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Health services research
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The non-variceal upper gastrointestinal bleeding is defined as gastrointestinal bleeding located proximal to the angle of Treitz, whose cause is not related to esophagogastric varices or gastropathy of portal hypertension. Animal studies showed no absorption in the GIT and disposal within 48 hours of application, and no reported cases of obstruction. Recently, a prospective study involving 20 patients with upper gastrointestinal bleeding, showed that the application of hemospray ® promoted hemostasis in 95% of cases, confirmed by endoscopic revision 72h after application without any complication.

Conditions

  • Upper Gastrointestinal Bleeding

Interventions

  • Metal clipsDevice

    The group will be shot of adrenaline 1: 10,000 in four quadrants, associated with application of metal clips.

  • HemosprayDrug

    The group will be shot of adrenaline 1: 10,000 in the four quadrants associated with application adsorption powder, marketed under the name Hemospray.

  • Endoscopy ExamProcedure

    All patients will be submitted to endoscopy exam in 12 to 24 hours after the therapeutic procedure to confirm the success of the therapy and measure if there the presence of rebleeding.

  • AdrenalineDrug

    The injection of adrenaline solution with 50% glucose at a proportion of 1: 10000 in four quadrants.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Initail hemostasis after endoscopic hemostatic procedureTime frame: up to 24 hours after endoscopic hemostatic procedure

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.